BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biomarkers For Immune Checkpoint Inhibitors

  Global Immune Checkpoint Inhibitors Biomarkers & Clinical Trials Insight 2028 Report Highlights.

  March 23, 2022

   · 

  4 min read
• Business

  Orum Therapeutics Appoints David Main to Board of Directors

  Orum Therapeutics today announced the appointment of David Main to the Company’s Board of Directors.

  March 23, 2022

   · 

  3 min read
• Drug Development

  Novocure Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 Study of Tumor Treating Fields in Ovarian Cancer

  Novocure (NASDAQ: NVCR) today announced the results of a pre-specified interim analysis for the phase 3 pivotal INNOVATE-3 study evaluating the safety and efficacy of Tumor Treating Fields (TTFields) together with paclitaxel for the treatment of patients with platinum-resistant ovarian cancer.

  March 23, 2022

   · 

  6 min read
• Biotech Beach

  Equillium Announces Two Oral Presentations at the Annual Meeting of the European Society for Blood and Marrow Transplantation

  Equillium, Inc., a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, announced two oral presentations at the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation.

  March 23, 2022

   · 

  10 min read
• OliX Pharmaceuticals to Participate in BIO-Europe Spring®

  OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today that the Company’s management will participate in one-on-one partnering meetings at BIO-Europe Spring.

  March 23, 2022

   · 

  1 min read